Please provide your email address to receive an email when new articles are posted on . Allergan is set to acquire the LifeCell regenerative medicine company from Acelity for $2.9 billion in cash, ...

SAN ANTONIO--(BUSINESS WIRE)--Acelity L.P. today announced a definitive agreement with Allergan for the acquisition of Acelity’s LifeCell business unit for $2.9 billion in cash. Upon completion of the ...

San Antonio medical technology company Acelity LP Inc. announced Tuesday it is selling LifeCell, its regenerative medicine business, to pharmaceutical giant Allergan for $2.9 billion in cash. The sale ...

SAN ANTONIO--(BUSINESS WIRE)--Acelity L.P. Inc. announced today that it has completed the sale of its regenerative medicine business unit, LifeCell Corporation, to Allergan for $2.9 billion in cash.

In the first week of December Acelity pulled its IPO, and now it is clear why. The private equity-owned woundcare group has sold its Lifecell unit to Allergan (AGN) for $2.9bn in cash, allowing ...

The Allergan logo is seen in this photo illustration November 23, 2015. To match special report USA-FDA/CASES REUTERS/Thomas White/Illustration/File Photo 33,623 people played the daily Crossword ...

It’s been a busy year of tuck-in deals for Allergan since its record-breaking Pfizer merger collapsed in April. And the company is sneaking in one more buyout agreement before 2016 draws to a close.

Allergan Restasis is facing stiff competition and near term earnings were going to be pressured. Allergan spent most of 2016 doing acquisitions with cash flows in the far future at very generous ...

Parsippany-Troy Hills, N.J.-based Allergan is acquiring LifeCell for $2.9 billion. Here’s what you should know. 1. LifeCell is a regenerative medicine company featuring several plastic surgery facing ...

Allergan has rounded off a particularly acquisitive 2016 – even by its own standards – with a $2.9bn deal to buy US regenerative medicine specialist LifeCell. While most of the dozen deals Allergan ...

Allergan has acquired regenerative medicine company LifeCell for $2.9 billion in cash, the company said Tuesday. The deal is expected to close early next year. LifeCell’s products include Acellular ...

Allergan plcAGN announced that it has signed a definitive agreement to acquire LifeCell, the regenerative medicine unit of Texas-based privately held company Acelity for $2.9 billion in cash. Allergan ...